Clinicopathological features of microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) in Japanese patients.

被引：0
|
作者：
Kawazoe, Akihito
Shitara, Kohei
Noguchi, Masaaki
Fukuoka, Shota
Kuboki, Yasutoshi
Bando, Hideaki
Okamoto, Wataru
Kojima, Takashi
Doi, Toshihiko
Ohtsu, Atsushi
Yoshino, Takayuki
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[4] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[5] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[6] Natl Canc Ctr Hosp East, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.629
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
629
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Mismatch repair (MMR) protein expression and next-generation sequencing (NGS) result in microsatellite instability-high (MSI-H) colorectal cancer
    Park, J. H.
    Han, H. S.
    VIRCHOWS ARCHIV, 2020, 477 : S193 - S193
  • [32] Clinicopathological and genomic characteristics of DNA Mismatch Repair-Deficient (dMMR) and microsatellite instability-high (MSI-H) resected gastric adenocarcinoma
    Zhou, J.
    Liang, B.
    Yin, M.
    Zhang, H.
    Liu, F.
    Dong, L.
    Zhang, B.
    Xu, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S921 - S922
  • [33] Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC.
    Diaz, Luis A.
    Marabelle, Aurelien
    Delord, Jean-Pierre
    Shapira-Frommer, Ronnie
    Geva, Ravit
    Peled, Nir
    Kim, Tae Won
    Andre, Thierry
    Van Cutsenn, Eric
    Guimbaud, Rosine
    Jaeger, Dirk
    Elez, Elena
    Yoshino, Takayuki
    Joe, Andrew K.
    Lam, Baohoang
    Gause, Christine K.
    Pruitt, Scott Knowles
    Kang, S. Peter
    Le, Dung T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Clinicopathological features of colorectal cancer patients according to level of microsatellite instability (MSI). The significance of MSI-L tumors
    Llor, X
    GASTROENTEROLOGY, 2004, 126 (04) : A199 - A199
  • [35] Response to nivolumab and ipilimumab in microsatellite instability-high (MSI-H) cervical carcinoma with acquired resistance to pembrolizumab
    Gim, Gahyun
    Cho, Sukjoo
    Lee, Dongyup
    Park, Jonghanne
    Kim, Leeseul
    Choi, Horyun
    Kang, Cyra Y.
    Vagia, Elena
    Viveiros, Pedro
    Chae, Young Kwang
    CANCER RESEARCH, 2020, 80 (16)
  • [36] Nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Five-year follow-up from CheckMate 142.
    Overman, Michael J.
    Lenz, Heinz-Josef
    Andre, Thierry
    Aglietta, Massimo
    Wong, Mark Ka
    Luppi, Gabriele
    Van Cutsem, Eric
    McDermott, Raymond S.
    Hendlisz, Alain
    Cardin, Dana Backlund
    Morse, Michael
    Neyns, Bart
    Hill, Andrew Graham
    Limon, M. Luisa
    Garcia-Alfonso, Pilar
    Krishnamurthy, Anuradha
    Chen, Franklin
    Abdullaev, Sandzhar
    Soleymani, Samira
    Lonardi, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)
    Lenz, H-J. J.
    Van Cutsem, E.
    Limon, M. L.
    Wong, K. Y.
    Hendlisz, A.
    Aglietta, M.
    Garcia-Alfonso, P.
    Neyns, B.
    Luppi, G.
    Cardin, D.
    Dragovich, T.
    Shah, U.
    Atasoy, A.
    Postema, R.
    Boyd, Z.
    Ledeine, J-M.
    Overman, M.
    Lonardi, S.
    ANNALS OF ONCOLOGY, 2018, 29 : 714 - 714
  • [38] Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
    Margalit, Ofer
    Stemmer, Amos
    Chapin, William J.
    Shacham-Shmueli, Einat
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    Pietrantonio, Filippo
    Boursi, Ben
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [39] A phase 3 study of nivolumab (NIVO), NIVO plus ipilimumab (IPI), or chemotherapy for microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): CheckMate 8HW
    Andre, T.
    Van Cutsem, E.
    Elez, E.
    Bennouna, J.
    de la Fouchardiere, C.
    Yoshino, T.
    Jensen, L.
    Mendez, G.
    Li, J.
    Goekkurt, E.
    Abdullaev, S.
    Chen, T.
    Lei, M.
    Lonardi, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S250 - S250
  • [40] Pembrolizumab (pembro) in microsatellite instability-high (MSI-H) advanced gastric/gastroesophageal junction (G/GEJ) cancer by line of therapy
    Chao, Joseph
    Fuchs, Charles S.
    Shitara, Kohei
    Tabernero, Josep
    Muro, Kei
    Van Cutsem, Eric
    Bang, Yung-Jue
    De Vita, Ferdinando
    Landers, Greg A.
    Yen, Chia-Jui
    Chau, Ian
    Elme, Anneli
    Lee, Jeeyun
    Ozguroglu, Mustafa
    Catenacci, Daniel V. T.
    Li, Xiaodong
    Shih, Chie-Schin
    Shah, Sukrut
    Bhagia, Pooja
    Wainberg, Zev A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345